Alexis Hermida-Jarry

Life-threatening events in patients with LQT3 on and off beta-blockers: Insights from a case series, by @ahermidaj and colleagues @CHUAmiens @hopitalbichat #EPeeps heartrhythmopen.com/article/S2666-…

Prognosis for loss-of-function versus hot-spot variants in RBM20-related cardiomyopathy @ahermidaj heartrhythmjournal.com/article/S1547-…

Systematic analysis of SCN5A variants associated with inherited cardiac diseases heartrhythmjournal.com/article/S1547-…

@hrs_journal @ADeliniere @CHUAmiens @amir_zouaghi @RythmologieLyon @EloiMarijon @victor_waldmann @JedraszakG @egandj @GuenanciaC @Gabriel40211637 @SandroNinni @WaintraubX @RodrigueGarcia4 @MartinsRaphae15 @LaredoMikael @BEYLS87 @jshermida

Online on the closing day of the Olympic Games 🏊‍♂️🥋⚽️🏀🏓. Publishing is also a sport, writing requires a long preparation . Three years of work, 362 SCN5A variants reviewed, more than 500 patients phenotyped. See the conclusions below👇! heartrhythmjournal.com/article/S1547-…

Check out our latest study on right and left atrial strain to identify high-risk NOAF patients in septic shock with bi-atrial dysfunction. @Crit_Care @ahermidaj @pierrehuette @CamilleDaumin link.springer.com/article/10.118…

la promotion 2024 des universitaires en Cardiologie. Felicitations à tous ! il nous reste à progresser vers la parité. Nous ne manquons pas de modèles féminins ⁦@heleltchaninoff⁩ ⁦@MartineGilard⁩ @marie-claudeMorice

I'm pleased to share this recently published article, in which we found no benefit from beta blockers in type 3 long QT syndrome heartrhythmjournal.com/article/S1547-…

Our data do not suggest that AKAP9 variants have a causal role in inherited cardiac diseases and indicate that AKAP9 screening is of limited clinical utility

From @ahermidaj+ Ader + team: NEXN Gene in Cardiomyopathies and Sudden Cardiac Deaths: Prevalence, Phenotypic Expression, and Prognosis ahajournals.org/doi/abs/10.116… @AHAScience #AHAjournals #CardioTwitter #Genetics 📽️@hj_tadros 🎙️@AnwarChahal

Cardiac #SBRT ☢️🎯 as a last-resort strategy for #LVAD patients with intractable VAs ⚡🌩️ Great collaboration with M.Lloyd @KHigginsMD from @EmoryUniversity, @ChuSaintEtienne and @GuenanciaC from @univbourgogne, in @JACCJournals tinyurl.com/yc6t4r4j

Just out @Circ_Gen! Phenotypic Characterization of Timothy Syndrome Caused by the CACNA1C p.Gly402Ser Variant doi.org/10.1161/CIRCGE… @RythmologieLyon @ahermidaj @BabkenAsatryan @HCL_research @FCardiogen @ERNGuardHeart

@jshermida @CHUAmiens What is your strategy? @SandroNinni @MartinsRaphae15 @pmlallemand @LaredoMikael @WaintraubX @RodrigueGarcia4

Ablation for PeAF ? Strategy @jshermida @CHUAmiens First step = cryo-PVI. Fast, safe. SR at 2 years = 51%. ajconline.org/article/S0002-… Second step for persistent ATa recurrence = linear lesions (CTI, roof, MI). SR at 3 years = 69%. sciencedirect.com/science/articl…

The accuracy of automated AF diagnoses varies between smart devices models: 👉Bordeaux Study: frontiersin.org/articles/10.33… 👉Basel Study: jacc.org/doi/10.1016/j.… You can also watch my presentation at #stimudef @rythmo_sfc with the help of @WaintraubX presentations.stimudef.org/presentation/2…

@BEYLS87 @osamaabouarab Thank you for your participation !

Congrats @ahermidaj and your team for your last paper ! @osamaabouarab sciencedirect.com/science/articl…

Two-year prognosis of ACS 🫀 during the 1st national lockdown 👉↘️ 30% ACS admission @CHUAmiens 👉no difference in MACE/death at the acute phase 👉no difference in MACE/death at 2 years @BEYLS87 @yohann_bohbot @osamaabouarab @SFCardio @ACVD 🇫🇷 sciencedirect.com/science/articl…

Check out the results of our last paper, the 🥳PARTY-PVI study🥳, analyzing the impact of various ablation strategies in patients with recurrent AF despite 4 PVs isolated, published in @CirculationEP 39 🇫🇷 centers, 367 patients @KarimBenali42 et al ahajournals.org/doi/abs/10.116… #Epeeps

@RevEspCardiol Ranolazine is effective in this young patient with Timothy syndrome type 2

Uso de ranolazina en paciente con síndrome de Timothy tipo 2 #REC #Cardiotwitter @ahermidaj revespcardiol.org//es-uso-ranola…